NCT07626619 Translation, Cultural Adaptation, and Standardization of E-NMQ
| NCT ID | NCT07626619 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Musculoskeletal Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 110 participants |
| Start Date | 2026-08-01 |
| Primary Completion | 2026-10-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 110 participants in total. It began in 2026-08-01 with a primary completion date of 2026-10-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary objective of this study is to translate the Nordic Musculoskeletal (E-NMQ) Questionnaire Modified Version into Urdu following international guidelines. Presently, there exists no validated tool to comprehensively measure symptoms such as pain, stiffness and weakness in Urdu-speaking patients in Pakistan. Specifically, the widely used E-NMQ, having these three vital categories, has yet to be translated and validated for Urdu-speaking individuals with musculoskeletal disease (MSD).
Eligibility Criteria
Inclusion Criteria: * Age between 18 and 45 years. * Both male and females * Able to speak and read Urdu language Individuals with a condition affecting the musculoskeletal system * Age matched healthy individual recruited will be either the attendants/family members accompanying patients in Jinnah Hospital or employees of Riphah International University. Exclusion Criteria: * Pregnant females, inflammation, local infection, fracture, suspected tumor, Recent surgery * Unwilling patients * Cognitive impairment \& speech impairment * Any neurological diseases (reflex changes \& loss of sensation)
Contact & Investigator
Hira Shaukat, Mphill
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07626619 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 45 Years, studying Musculoskeletal Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07626619 currently recruiting?
Yes, NCT07626619 is actively recruiting participants. Contact the research team at Imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT07626619 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07626619 clinical trial?
NCT07626619 is sponsored by Riphah International University. The principal investigator is Hira Shaukat, Mphill at Riphah International University. The trial plans to enroll 110 participants.